Select Publications

Book Chapters

Baysari M; Chan J; Carland J; Stocker S; Moran M; Day R, 2018, 'Usability of Reports Generated by a Computerised Dose Prediction Software', in Connecting the System to Enhance the Practitioner and Consumer Experience in Healthcare, IOS Press, Netherlands, pp. 27 - 32, http://dx.doi.org/10.3233/978-1-61499-890-7-27

Day R; pile KD; graham GG; katelaris C, 2016, 'Antimalarial Drugs', in Compendium of Inflammatory Diseases, Springer Basel, Basel, pp. 97 - 101, http://dx.doi.org/10.1007/978-3-7643-8550-7

Day R; graham GG, 2016, 'Coxibs', in Compendium of Inflammatory Diseases, Springer Basel, pp. 1 - 7, http://dx.doi.org/10.1007/978-3-0348-0620-6_22-1

Graham GG; Roberts MS; Day RO; Rainsford KD, 2016, 'Pharmacokinetics and metabolism of the salicylates', in Aspirin and Related Drugs, pp. 97 - 155

Day RO; Graham GG, 2013, 'Non-steroidal anti-inflammatory drugs', in Encyclopedia of Inflammatory Diseases, edn. 6, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Graham GG; Williams KM, 2013, 'Propionic acid derivative drugs (Profens)', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Graham GG; Day RO, 2013, 'Salicylates', in Encyclopedia of Inflammatory Diseases, Springer-Verlag, Berlin Heidelberg, http://www.springerreference.com/

Day RO; Williams KM; Graham GG, 2013, 'Urate-lowering therapy: Uricosurics', in Dalbeth N; Peresa-Ruiz F; Schlesinger N (ed.), Gout, Future Medicine Ltd, pp. 174 - 188, http://dx.doi.org/10.2217/ebo.13.104

Pile K; Graham GG; Mahler SM; Day RO, 2011, 'Disease modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 585 - 619, http://books.google.com.au/books?id=X0deXiGtcCAC&printsec=frontcover#v=onepage&q&f=false

Baysari MT; Westbrook J; Day RO, 2011, 'Medication decision-making on hospital ward-rounds', in Moen A; Andersen SK; Aarts J; Hurlen P (ed.), Studies in Health Technology and Informatics, IOS Press, Amsterdam, pp. 935 - 939, http://dx.doi.org/10.3233/978-1-60750-806-9-935

Bachmeier CJ; Brooks PM; Day RO; Graham GG; Littlejohn GO; Morand E; Pile K; Williams KM, 2005, 'Disease-modifying anti-rheumatic drugs (DMARD)', in Nijkamp FJ; Parnham MJ (ed.), Principles of Immunopharmacology (2nd Ed), edn. 2nd, Birkhauser Verlag, Basel, pp. 511 - 544

Day RO, 2003, 'Therapy of osteoarthritis', in Scott D; Cope A (ed.), The Year in Rheumatic Disorders 2003, edn. First, Clinical Publishibg Services Ltd, Oxford, United Kingdom, pp. 23 - 34

Day RO; Quinn DE; Williams KK; Handel ML; Brooks PM, 2000, 'Connective tissue and bone disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702

Day RO, 2000, 'Rheumatic Disorders', in Melmon and Morrelli`s clinical pharmacology: basic principles in therapeutics, edn. Original, McGrath Hill, New York, pp. 645 - 702

Day RO; Quinn DI; March LM; Graham GG; Williams KM, 2000, 'Rheumatoid arthritis. New Frontiers in pathogenesis and treatment', in NSAIDs and analgesics, edn. Original, Oxford University Press, Oxford, England, pp. 307 - 328

Brady S; Day RO; Graham GG, 1999, 'Are Intra-Articular steroids as effective?', in Challenges in Rheumatoid Arthritis, edn. Original, Blackwell Science, Oxford, UK, pp. 174 - 189

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1999, 'Disease-modifying antirheumatic drugs', in Nijkamp FP; Parnham MJ (ed.), Principles of Immunopharmacology, edn. 3, Birkhauser Verlag (Springer), Basel, Switzerland, pp. 379 - 403

Graham GG; Milligan MK; Day RO; Williams KM; Ziegler JB, 1998, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in Rainsford KD; Powanda MC (ed.), Safety and Efficacy of non-prescription (OTC) analgesics and NSAIDs, Kluwer Academic Publishers, Dordrecht, pp. 77 - 92, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000081416000006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Brooks PM; Savdie E; Day RO, 1998, 'Antirheumatic drugs and renal disease', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 28 - 29

Brooks PM; Day RO, 1998, 'Arthritis', in Drug Therapy in old age, edn. Original, Wiley & Sons, Chichester UK, pp. 387 - 400

Bachmeier CJ; Handel ML; Conaghan PG; Williams KM; Graham GG; Brooks PM; Day RO, 1998, 'Disease Modifying antirheumatic drugs', in Textbook of Immunopharmacology, edn. 3, Burkhauser, Basel, Switzerland, pp. 183 - 190, http://dx.doi.org/10.1097/00002281-199705000-00003

Day RO, 1998, 'Formulary and Guide to Prescribing (second edition)', in Formulary Guide to Prescribing (2nd Ed), edn. Original, St. Vincent's Hospital, Sydney, Australia, pp. 1 - 445

Yeomans N; Brooks PM; Day RO, 1998, 'Non steroidal anti-inflammatory drugs and peptic ulceration', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 27 - 28

Day RO, 1998, 'SARDS', in Rheumatology (2nd Ed), edn. Original, Gower, London, pp. 8.1 - 8.10

Quinn DE; Day RO, 1997, 'Guide to Clinically More Important Drug Interactions.', in Drug Safety, edn. Original, Adis International Limited, Auckland, New Zealand, pp. 1665 - 1700

Day RO, 1997, 'Sulfasalazine.', in In: `The Textbook of Rheumatology`, Edition 5., edn. Original, pp. 741 - 746

Graham GG; Milligan MK; Day RO; Williams KM; Zeig , 1997, 'Therapeutic considerations from pharmacokinetics and metabolism: ibuprofen and paracetamol', in In: `Safety and efficacy of non-prescription (OTC) analgesics, edn. Original, Kluwer Academic Publishers, Great Britain, pp. 77 - 92

Journal articles

Stocker SL; Carland JE; Reuter SE; Stacy AE; Schaffer AL; Stefani M; Lau C; Kirubakaran R; Yang JJ; Shen CFJ; Roberts DM; Marriott DJE; Day RO; Brett J, 2020, 'Evaluation of a pilot vancomycin precision dosing advisory service on target exposure attainment using an interrupted time series analysis.', Clin Pharmacol Ther, http://dx.doi.org/10.1002/cpt.2113

Uster DW; Stocker SL; Carland JE; Brett J; Marriott DJE; Day RO; Wicha SG, 2020, 'A Model Averaging/Selection Approach Improves the Predictive Performance of Model-Informed Precision Dosing: Vancomycin as a Case Study', CLINICAL PHARMACOLOGY & THERAPEUTICS, http://dx.doi.org/10.1002/cpt.2065

Shingde RV; Reuter SE; Graham GG; Carland JE; Williams KM; Day RO; Stocker SL, 2020, 'Assessing the accuracy of two Bayesian forecasting programs in estimating vancomycin drug exposure', The Journal of antimicrobial chemotherapy, vol. 75, pp. 3293 - 3302, http://dx.doi.org/10.1093/jac/dkaa320

Kirubakaran R; Stocker SL; Hennig S; Day RO; Carland JE, 2020, 'Population Pharmacokinetic Models of Tacrolimus in Adult Transplant Recipients: A Systematic Review', Clinical Pharmacokinetics, vol. 59, pp. 1357 - 1392, http://dx.doi.org/10.1007/s40262-020-00922-x

Te West N; Day R; Graham G; Wright M; White C; Popovic G; Moore KH, 2020, 'Serum concentrations of estriol vary widely after application of vaginal estriol cream.', Br J Clin Pharmacol, http://dx.doi.org/10.1111/bcp.14635

Xu A; Baysari MT; Stocker SL; Leow LJ; Day RO; Carland JE, 2020, 'Researchers' views on, and experiences with, the requirement to obtain informed consent in research involving human participants: A qualitative study', BMC Medical Ethics, vol. 21, pp. 93, http://dx.doi.org/10.1186/s12910-020-00538-7

Coulshed A; Nguyen AD; Stocker SL; Day RO, 2020, 'Australian patient perspectives on the impact of gout', International Journal of Rheumatic Diseases, vol. 23, pp. 1372 - 1378, http://dx.doi.org/10.1111/1756-185X.13934

Day R; Nguyen A; Graham G; Aung E; Coleshill M; Stocker S, 2020, 'Better outcomes for patients with gout', Inflammopharmacology, vol. 28, pp. 1395 - 1400, http://dx.doi.org/10.1007/s10787-020-00694-7

Machado GC; Ghinea N; Rogan E; Day RO; Maher CG, 2020, 'Emergency department care for low back pain: Should we adopt recommendations from primary care guidelines?', EMA - Emergency Medicine Australasia, vol. 32, pp. 890 - 892, http://dx.doi.org/10.1111/1742-6723.13593

Raban MZ; Lind KE; Day RO; Gray L; Georgiou A; Westbrook JI, 2020, 'Trends, determinants and differences in antibiotic use in 68 residential aged care homes in Australia, 2014-2017: a longitudinal analysis of electronic health record data', BMC Health Services Research, vol. 20, pp. 883, http://dx.doi.org/10.1186/s12913-020-05723-3

Chaudhri K; Stocker SL; Williams KM; McLeay RC; Marriott DJE; Di Tanna GL; Day RO; Carland JE, 2020, 'Voriconazole: An audit of hospital-based dosing and monitoring and evaluation of the predictive performance of a dose-prediction software package', Journal of Antimicrobial Chemotherapy, vol. 75, pp. 1981 - 1984, http://dx.doi.org/10.1093/jac/dkaa098

Badve SV; Pascoe EM; Tiku A; Boudville N; Brown FG; Cass A; Clarke P; Dalbeth N; Day RO; De Zoysa JR; Douglas B; Faull R; Harris DC; Hawley CM; Jones GRD; Kanellis J; Palmer SC; Perkovic V; Rangan GK; Reidlinger D; Robison L; Walker RJ; Walters G; Johnson DW, 2020, 'Effects of allopurinol on the progression of chronic kidney disease', New England Journal of Medicine, vol. 382, pp. 2504 - 2513, http://dx.doi.org/10.1056/NEJMoa1915833

Liu C; Abdel Shaheed C; McLachlan AJ; Latimer J; Li Q; Buchbinder R; Day RO; Maher CG; Richards B; Oliveira JS; Lin CWC, 2020, 'OASIS-a randomised, placebo-controlled trial of oral glucocorticoids for leg pain in patients with acute sciatica: trial protocol', BMJ open, vol. 10, pp. e040559, http://dx.doi.org/10.1136/bmjopen-2020-040559

Ghinea N; Wiersma M; Kerridge I; Olver I; Pearson S; Day R; Liauw W; Lipworth W, 2020, '“Some sort of fantasy land”: A qualitative investigation of appropriate prescribing in cancer care', Journal of Evaluation in Clinical Practice, vol. 26, pp. 747 - 754, http://dx.doi.org/10.1111/jep.13278

Brett J; Anthony C; Day R, 2020, 'Off-label quetiapine prescribing in general hospital inpatients', Journal of Pharmacy Practice and Research, http://dx.doi.org/10.1002/jppr.1608

Van Dort BA; Baysari MT; Carland JE; Stocker SL; Braithwaite HE; Fernon AR; Day RO, 2020, 'Education to improve vancomycin use: the perspectives of educators and education recipients', Internal Medicine Journal, vol. 50, pp. 565 - 572, http://dx.doi.org/10.1111/imj.14408

Milder TY; Day RO; Stocker SL; Greenfield JR, 2020, 'Should the cardio-protective properties of sodium-glucose cotransporter 2 inhibitors dictate therapeutic decision-making in patients with type 2 diabetes', Internal Medicine Journal, vol. 50, pp. 645 - 646, http://dx.doi.org/10.1111/imj.14819

te West NID; Day RO; Hiley B; White C; Wright M; Moore KH, 2020, 'Estriol serum levels in new and chronic users of vaginal estriol cream: A prospective observational study', Neurourology and Urodynamics, vol. 39, pp. 1137 - 1144, http://dx.doi.org/10.1002/nau.24331

Nguyen AD; Lind KE; Day RO; Georgiou A; Westbrook JI, 2020, 'A profile of health status and demographics of aged care facility residents with gout', Australasian Journal on Ageing, vol. 39, pp. e153 - e161, http://dx.doi.org/10.1111/ajag.12716

Lowenstein D; Zheng WY; Burke R; Kenny E; Sandhu A; Makeham M; Westbrook J; Day RO; Baysari MT, 2020, 'Do user preferences align with human factors assessment scores of drug–drug interaction alerts?', Health Informatics Journal, vol. 26, pp. 563 - 575, http://dx.doi.org/10.1177/1460458219840210

Abdel Shaheed C; Maher CG; Buchbinder R; Ng B; Enke O; Guzowski R; McLachlan AJ; Day RO; Richards B; Latimer J; Lin CWC, 2020, 'Efficacy and harms of orally, intramuscularly or intravenously administered glucocorticoids for sciatica: A systematic review and meta-analysis', European Journal of Pain (United Kingdom), vol. 24, pp. 518 - 535, http://dx.doi.org/10.1002/ejp.1505

Day RO; Coleshill MJ; Stocker SL; Nguyen AD; Robinson P; Aung E, 2020, 'Predictors of success in gout treatment', Journal of Rheumatology, vol. 47, pp. 313 - 315, http://dx.doi.org/10.3899/jrheum.191150

Smith FC; Stocker SL; Danta M; Carland JE; Kumar SS; Liu Z; Greenfield JR; Braithwaite HE; Cheng TS; Graham GG; Williams KM; Day RO, 2020, 'The safety and pharmacokinetics of metformin in patients with chronic liver disease', Alimentary Pharmacology and Therapeutics, vol. 51, pp. 565 - 575, http://dx.doi.org/10.1111/apt.15635


Back to profile page